These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1545404

  • 1. Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine.
    Chang T, Levine M, Bellward GD.
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1450-5. PubMed ID: 1545404
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine.
    Chang T, Levine M, Bandiera SM, Bellward GD.
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1441-9. PubMed ID: 1545403
    [Abstract] [Full Text] [Related]

  • 3. In vivo and in vitro effects of beta-naphthoflavone on cytochrome P-450-dependent testosterone hydroxylase activities in liver microsomes.
    Shiverick KT.
    Drug Metab Dispos; 1981 Mar; 9(6):545-50. PubMed ID: 6120814
    [Abstract] [Full Text] [Related]

  • 4. Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats.
    Cadario BJ, Bellward GD, Bandiera S, Chang TK, Ko WW, Lemieux E, Pak RC.
    Mol Pharmacol; 1992 May; 41(5):981-8. PubMed ID: 1588929
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
    Reidy GF, Mehta I, Murray M.
    Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
    [Abstract] [Full Text] [Related]

  • 6. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
    Stevens JC, Halpert J.
    Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
    Fisher D, Labbe G, Berson A, Tinel M, Loeper J, Larrey D, Pessayre D.
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
    Bast A, Savenije-Chapel EM, Kroes BH.
    Xenobiotica; 1984 May; 14(5):399-408. PubMed ID: 6089451
    [Abstract] [Full Text] [Related]

  • 9. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
    Murray M, Reidy GF.
    Drug Metab Dispos; 1989 May; 17(4):449-54. PubMed ID: 2571488
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
    Grubb MF, Diamond S, Christ DD.
    Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
    [Abstract] [Full Text] [Related]

  • 11. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
    Levine M, Law EY, Bandiera SM, Chang TK, Bellward GD.
    J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789
    [Abstract] [Full Text] [Related]

  • 12. Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex.
    Levine M, Bellward GD.
    Drug Metab Dispos; 1995 Dec; 23(12):1407-11. PubMed ID: 8689952
    [Abstract] [Full Text] [Related]

  • 13. Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats.
    LeBlanc GA, Sundseth SS, Weber GF, Waxman DJ.
    Cancer Res; 1992 Feb 01; 52(3):540-7. PubMed ID: 1732040
    [Abstract] [Full Text] [Related]

  • 14. Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat.
    Drew R, Rowell J, Grygiel JJ.
    Res Commun Chem Pathol Pharmacol; 1981 Jul 01; 33(1):81-93. PubMed ID: 7268211
    [Abstract] [Full Text] [Related]

  • 15. Cimetidine: an inhibitor and an inducer of rat liver microsomal cytochrome P-450.
    Wright AW, Winzor DJ, Reilly PE.
    Xenobiotica; 1991 Feb 01; 21(2):193-203. PubMed ID: 2058175
    [Abstract] [Full Text] [Related]

  • 16. Selective suppression of rat hepatic cytochrome P450 2C11 by chloramphenicol.
    Kraner JC, Morgan ET, Halpert JR.
    J Pharmacol Exp Ther; 1994 Sep 01; 270(3):1367-72. PubMed ID: 7932191
    [Abstract] [Full Text] [Related]

  • 17. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M, Butler AM, Stupans I.
    J Pharmacol Exp Ther; 1994 Aug 01; 270(2):645-9. PubMed ID: 8071856
    [Abstract] [Full Text] [Related]

  • 18. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP.
    Chem Res Toxicol; 1997 Jan 01; 10(1):91-102. PubMed ID: 9074808
    [Abstract] [Full Text] [Related]

  • 19. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
    Tephly TR, Black KA, Green MD, Coffman BL, Dannan GA, Guengerich FP.
    Mol Pharmacol; 1986 Jan 01; 29(1):81-7. PubMed ID: 3080674
    [Abstract] [Full Text] [Related]

  • 20. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects].
    Carrasco M, Gaule C, Vega P, del Villar E.
    Rev Med Chil; 1992 May 01; 120(5):539-44. PubMed ID: 1364175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.